Guiding Principles, Attributes, and Process to Review Medical Management Guidelines

PEDIATRICS ◽  
2001 ◽  
Vol 108 (6) ◽  
pp. 1378-1382 ◽  
Keyword(s):  
Medical Management ◽  
Management Guidelines ◽  
Guiding Principles

scholarly journals Aspirin Allergy Desensitization in Cerebrovascular Disease

2014 ◽  
Vol 20 (1) ◽  
pp. 5-11 ◽  
Author(s):  
Scott L Zuckerman ◽  
David B Seder ◽  
Crystiana Tsujiura ◽  
Deborah Cushing ◽  
Holly Gallup ◽  
...  
Keyword(s):  
Cerebrovascular Disease ◽  
Vascular Disease ◽  
Medical Management ◽  
Relevant Literature ◽  
Management Guidelines ◽  
Comprehensive Management ◽  
Subsequent Literature

Aspirin (ASA) is the mainstay of treatment in cerebrovascular and systemic vascular disease. ASA hypersensitivity can pose a challenge to achieving optimum medical management prior to and after neurointerventional treatment. Desensitization to ASA is well described in the allergy and cardiovascular literature, but there are no similar discussions specific to neurointervention. The purpose of our study was to describe our experience with ASA hypersensitivity management and review the relevant literature. Two cases of patients with symptomatic cerebrovascular disease requiring neurointervention who were successfully desensitized to their ASA hypersensitivity prior to treatment are described. The subsequent literature is reviewed. Several ASA desensitization protocols exist and have been proven to successfully treat ASA hypersensitivity and allow for ASA therapy to be safely initiated. We describe several previously published protocols. ASA desensitization is a safe and simple way to manage ASA hypersensitivity. We provide comprehensive management guidelines for the neurointerventionalist engaging in ASA desensitization.

Drug-Induced Movement Disorders

2015 ◽  
Vol 25 (2) ◽  
pp. 70-77
Author(s):  
Amy Lustig ◽  
Cesar Ruiz
Keyword(s):  
Movement Disorders ◽  
Medical Management ◽  
Disease Process ◽  
Underlying Disease ◽  
Extrapyramidal Symptoms ◽  
Drug Induced ◽  
General Overview ◽  
Management Approaches ◽  
Broad Understanding ◽  
Underlying Disease Process

The purpose of this article is to present a general overview of the features of drug-induced movement disorders (DIMDs) comprised by Parkinsonism and extrapyramidal symptoms. Speech-language pathologists (SLPs) who work with patients presenting with these issues must have a broad understanding of the underlying disease process. This article will provide a brief introduction to the neuropathophysiology of DIMDs, a discussion of the associated symptomatology, the pharmacology implicated in causing DIMDs, and the medical management approaches currently in use.

1438: Benign Prostatic Hyperplasia Outcomes 12 Months after Initiating Medical Management: An Analysis of Managed Care Data

2006 ◽  
Vol 175 (4S) ◽  
pp. 464-465
Author(s):  
Michael J. Naslund ◽  
Muta M. Issa ◽  
Libby Black ◽  
Michael Eaddy ◽  
Manan Shah
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Managed Care ◽  
Medical Management ◽  
Prostatic Hyperplasia

7: Differences in Medical Management of LUTS/BPH between PCPS and Urologists

2006 ◽  
Vol 175 (4S) ◽  
pp. 3-3 ◽  
Author(s):  
John T. Wei ◽  
James Nuckolls ◽  
Martin Miner ◽  
Raymond C. Rosen ◽  
Claus G. Roehrborn
Keyword(s):  
Medical Management
Sign in / Sign up

Export Citation Format

Share Document